3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
66
Carcinoma, Renal Cell
38
Liver Neoplasms
20
Neoplasm Metastasis
17
Carcinoma, Non-Small-Cell Lung
16
Neoplasms
15
Breast Neoplasms
15
Melanoma
13
Thyroid Neoplasms
10
Leukemia, Myeloid, Acute
10
Sarcoma
9
Lung Neoplasms
8
Kidney Neoplasms
8
Prostatic Neoplasms
7
Ovarian Neoplasms
7
Urinary Bladder Neoplasms
6
Pancreatic Neoplasms
6
Glioblastoma
6
Brain Neoplasms
6
Colorectal Neoplasms
5
Carcinoma, Medullary
5
Thyroid Carcinoma, Anaplastic
4
Stomach Neoplasms
4
Rectal Neoplasms
4
Gliosarcoma
4
Gallbladder Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms, Male
4
Thyroid Diseases
3
Thyroid Cancer, Papillary
3
Interventions
Carboplatin
15
Etoposide
14
Ifosfamide
11
Paclitaxel
10
Filgrastim
10
Cisplatin
10
Thiotepa
5
Peripheral Blood Stem Cell Transplantation
5
Gemcitabine
5
pegfilgrastim
4
Cyclophosphamide
4
Bleomycin
4
etoposide phosphate
3
Oxaliplatin
3
Methylprednisolone
3
Epirubicin
3
sargramostim
2
aldesleukin
2
Stem Cell Transplantation
2
Prednisone
2
Methotrexate
2
Mesna
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Docetaxel
2
Dexamethasone
2
Brentuximab Vedotin
2
Arsenic Trioxide
2
Amifostine
2
Alemtuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Testicular Neoplasms
×
Sorafenib
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled